GlaxoSmithKline, in its latest financial result recorded a 232 percent increase in investment income to N310.3 million, the highest in the last four years.
The increase in investment income was spearheaded by 232 percent increase in interest income from short term deposits to N310.3 million in 20
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
Folake Balogun
Folake Balogun is a tech journalist covering Africa’s fast-growing digital economy with a strong focus on incisive analysis of startup trends, venture capital, and fintech innovation, while also exploring emerging technologies such as artificial intelligence and the future of connectivity by highlighting their economic and social impact.
